Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma
ASPIRE Trial - KRd VS Rd - Multiple Myeloma Clinical Trials
Clinical Trials in R/R Multiple Myeloma
Healthcare reality of the treatment of the high-risk multiple myeloma in Spain | Medicina Clínica (English Edition)
Biomedicines | Free Full-Text | Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting
Additional Abstracts of Interest in Multiple Myeloma at ASH 2015 | Research To Practice
Multiple myeloma | Nature Reviews Disease Primers
Carfilzomib in multiple myeloma | PPT
Takeda Oncology on X: "Multiple #myeloma may be the most common, but DYK there are several other forms of myeloma? Take action, learn more https://t.co/aDKofURa4c https://t.co/aFizSxMTn0" / X
Emerging immunotherapies in multiple myeloma | The BMJ
Healthcare reality of the treatment of the high-risk multiple myeloma in Spain | Medicina Clínica (English Edition)
Carfilzomib in multiple myeloma | PPT
Multiple myeloma treatment and management in the elderly. | Semantic Scholar
Additional Abstracts of Interest in Multiple Myeloma at ASH 2015 | Research To Practice
Amgen's Phase III ASPIRE trial of myeloma treatment Kyprolis meets primary endpoint - Clinical Trials Arena
Current Oncology | Free Full-Text | Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group - The Lancet Oncology
Frontiers | Therapeutic strategies to enhance immune response induced by multiple myeloma cells
Extramedullary multiple myeloma | Leukemia
Multiple myeloma, causes, symptoms, diagnosis, newest treatment & prognosis
Cardiovascular Complications of Novel Multiple Myeloma Treatments | Circulation
Efficacy and safety of carfilzomib for the treatment of multiple myeloma: An overview of systematic reviews - ScienceDirect
How I treat high-risk multiple myeloma - ScienceDirect
Multiple myeloma | Nature Reviews Disease Primers
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors
